Global Reproductive Genetics Market

Reproductive Genetics Comprehensive Study by Type (Laboratory Developed Tests (LDT), Kits, Reagents and Consumables), Application (Aneuploidy, Single Gene Disorders, Structural Abnormalities, Others), Technology (PCR, Sequencing, In-Situ Hybridization (ISH), Comparative Genomic Hybridization (CGH), Microarray, Polymerase Chain Reaction (PCR)), Procedure (Pre-Natal Screening, Pre-Implantation Genetic Testing, Infertility Genetic Testing, Carrier Screening) Players and Region - Global Market Outlook to 2027

Reproductive Genetics Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Reproductive Genetics Market Scope
Reproductive Genetics is concerned with the genetic and epigenetic aspects of both natural and assisted reproduction. Because of the rapid technological advances, it is a field that is constantly evolving, and it is our focus to constantly explore how technologies can be used to help understand the biology of reproduction. Individuals who want to know and/or have some control over their children's genetic makeup are using genetic reproductive technologies for a variety of reasons. A variety of techniques enables doctors to obtain genetic material from a foetus in the womb and analyse it genetically. Simultaneously, the advancement of technologies for creating embryos in a lab - the process of in vitro fertilisation (IVF) - has resulted in the ability to perform genetic analysis on these embryos prior to implanting them into the womb. These reproductive technologies enable us to screen, select, and, one day; modify offspring to eliminate deadly or crippling diseases. Simultaneously, they raise concerns about disability rights, discrimination, and eugenics.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledAgilent Technologies, Inc. (United States), BGI (China), CENTOGENE AG (Germany), Fulgent Genetics, Inc. (United States), F. Hoffmann-La Roche Ltd (Switzerland), Igenomix (Spain), Illumina, Inc. (United States), Invitae Corporation (United States), Laboratory Corporation of America Holdings (United States) and PerkinElmer, Inc. (United States)
CAGR%


To entice more end users, market players are focusing on providing Reproductive Genetics of higher quality while adhering to all regulatory standards. In the global reproductive genetics market, there are numerous large and small-scale service providers. They are also concentrating on the implementation of numerous advanced technologies. Furthermore, the numerous industry profits have led to the entry of new players, raising the level of rivalry in an already competitive market. The reproductive genetics market is currently expanding due to the rapid advancement of molecular science and the increased use of genetic tests. Some of the market's key players' strategies include new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Reproductive Genetics market throughout the predicted period.

Agilent Technologies, Inc. (United States), BGI (China), CENTOGENE AG (Germany), Fulgent Genetics, Inc. (United States), F. Hoffmann-La Roche Ltd (Switzerland), Igenomix (Spain), Illumina, Inc. (United States), Invitae Corporation (United States), Laboratory Corporation of America Holdings (United States) and PerkinElmer, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Myriad Genetics, Inc. (United States), OPKO Health, Inc. (United States), Quest Diagnostics (United States), QIAGEN N.V. (Germany) and Thermo Fisher Scientific Inc. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Reproductive Genetics market by Type , by Application (Aneuploidy, Single Gene Disorders, Structural Abnormalities and Others) and Region with country level break-up.

On the basis of geography, the market of Reproductive Genetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
In February 2022, Agilent Technologies Inc. announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine teaching software developer that creates innovative analysis solutions in lab testing. Agilent will integrate the software, known as ACIES, into its industry-leading gas chromatography and mass spectrometry (GS/MS) platforms to improve the productivity, efficiency, and accuracy of high-throughput labs the company serves around the world.
OneCellDx and the Genetics Institute of America said on May 2022 that they have signed a diagnostics commercialization agreement for OneCellDx's OncoPredikt HRD Assay. Under the deal, GIA will create a laboratory-developed test based on OneCellDx's proprietary, artificial intelligence-enabled algorithm and assay, which is designed to identify genomic signatures associated with homologous recombination deficiency in cancer patients.
Analysis of current law demonstrates that the responses of state and federal governments and the legal system to reproductive genetic testing both have shaped the development of and reflect society's views about these techniques. Access to testing has been increased by the governmental provision of services and enactment of insurance requirements and by the state courts' frequent approval of individual litigants' claims that they were inappropriately denied genetic information. Many state legislatures, however, have tried to limit testing by failing to provide funds, forbidding private lawsuits, and by limiting access to abortion.

Reproductive Genetics Market Dynamics:
AttributesDetails
Trends Influencing Market
  • Declining Cost of Genetic Sequencing Technologies and Rising Emphasis on Early Detection and Prevention has Been Contributing towards Market Growth.
Key Restraints
  • Ethical and Social Issues Related to Selection of gender and Others Have Been Restraining the Market Growth.
Challenges
  • Lack of Regulations had made it Convenient to Perform the Process with Approval and Have Non-Medical Use, Which Has Been Challenging for the Market.
Market Opportunities
  • Shifting of Reimbursement Policies toward Enhanced Genetic Testing Coverage and Rising Funding and Innovations have Been Increasing Consumer Demand, Which Will Be Providing Better Opportunities for Market Growth.


Key Target Audience
Biotechnology companies, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Laboratory Developed Tests (LDT)
  • Kits
  • Reagents and Consumables
By Application
  • Aneuploidy
  • Single Gene Disorders
  • Structural Abnormalities
  • Others
By Technology
  • PCR
  • Sequencing
  • In-Situ Hybridization (ISH)
  • Comparative Genomic Hybridization (CGH)
  • Microarray
  • Polymerase Chain Reaction (PCR)

By Procedure
  • Pre-Natal Screening
  • Pre-Implantation Genetic Testing
  • Infertility Genetic Testing
  • Carrier Screening

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness and Acceptance for Genetic Testing and Screening and Rising Maternal Age Leading to Pregnancy Complications Has Been Driving the Market Growth.
    • 3.3. Market Challenges
      • 3.3.1. Lack of Regulations had made it Convenient to Perform the Process with Approval and Have Non-Medical Use, Which Has Been Challenging for the Market.
    • 3.4. Market Trends
      • 3.4.1. Declining Cost of Genetic Sequencing Technologies and Rising Emphasis on Early Detection and Prevention has Been Contributing towards Market Growth.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Reproductive Genetics, by Type, Application, Technology, Procedure and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Reproductive Genetics (Value)
      • 5.2.1. Global Reproductive Genetics by: Type (Value)
        • 5.2.1.1. Laboratory Developed Tests (LDT)
        • 5.2.1.2. Kits
        • 5.2.1.3. Reagents and Consumables
      • 5.2.2. Global Reproductive Genetics by: Application (Value)
        • 5.2.2.1. Aneuploidy
        • 5.2.2.2. Single Gene Disorders
        • 5.2.2.3. Structural Abnormalities
        • 5.2.2.4. Others
      • 5.2.3. Global Reproductive Genetics by: Technology (Value)
        • 5.2.3.1. PCR
        • 5.2.3.2. Sequencing
        • 5.2.3.3. In-Situ Hybridization (ISH)
        • 5.2.3.4. Comparative Genomic Hybridization (CGH)
        • 5.2.3.5. Microarray
        • 5.2.3.6. Polymerase Chain Reaction (PCR)
      • 5.2.4. Global Reproductive Genetics by: Procedure (Value)
        • 5.2.4.1. Pre-Natal Screening
        • 5.2.4.2. Pre-Implantation Genetic Testing
        • 5.2.4.3. Infertility Genetic Testing
        • 5.2.4.4. Carrier Screening
      • 5.2.5. Global Reproductive Genetics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Reproductive Genetics (Price)
      • 5.3.1. Global Reproductive Genetics by: Type (Price)
  • 6. Reproductive Genetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BGI (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CENTOGENE AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Fulgent Genetics, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Igenomix (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Illumina, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Invitae Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Laboratory Corporation of America Holdings (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PerkinElmer, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Reproductive Genetics Sale, by Type, Application, Technology, Procedure and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Reproductive Genetics (Value)
      • 7.2.1. Global Reproductive Genetics by: Type (Value)
        • 7.2.1.1. Laboratory Developed Tests (LDT)
        • 7.2.1.2. Kits
        • 7.2.1.3. Reagents and Consumables
      • 7.2.2. Global Reproductive Genetics by: Application (Value)
        • 7.2.2.1. Aneuploidy
        • 7.2.2.2. Single Gene Disorders
        • 7.2.2.3. Structural Abnormalities
        • 7.2.2.4. Others
      • 7.2.3. Global Reproductive Genetics by: Technology (Value)
        • 7.2.3.1. PCR
        • 7.2.3.2. Sequencing
        • 7.2.3.3. In-Situ Hybridization (ISH)
        • 7.2.3.4. Comparative Genomic Hybridization (CGH)
        • 7.2.3.5. Microarray
        • 7.2.3.6. Polymerase Chain Reaction (PCR)
      • 7.2.4. Global Reproductive Genetics by: Procedure (Value)
        • 7.2.4.1. Pre-Natal Screening
        • 7.2.4.2. Pre-Implantation Genetic Testing
        • 7.2.4.3. Infertility Genetic Testing
        • 7.2.4.4. Carrier Screening
      • 7.2.5. Global Reproductive Genetics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Reproductive Genetics (Price)
      • 7.3.1. Global Reproductive Genetics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Reproductive Genetics: by Type(USD Million)
  • Table 2. Reproductive Genetics Laboratory Developed Tests (LDT) , by Region USD Million (2016-2021)
  • Table 3. Reproductive Genetics Kits , by Region USD Million (2016-2021)
  • Table 4. Reproductive Genetics Reagents and Consumables , by Region USD Million (2016-2021)
  • Table 5. Reproductive Genetics: by Application(USD Million)
  • Table 6. Reproductive Genetics Aneuploidy , by Region USD Million (2016-2021)
  • Table 7. Reproductive Genetics Single Gene Disorders , by Region USD Million (2016-2021)
  • Table 8. Reproductive Genetics Structural Abnormalities , by Region USD Million (2016-2021)
  • Table 9. Reproductive Genetics Others , by Region USD Million (2016-2021)
  • Table 10. Reproductive Genetics: by Technology(USD Million)
  • Table 11. Reproductive Genetics PCR , by Region USD Million (2016-2021)
  • Table 12. Reproductive Genetics Sequencing , by Region USD Million (2016-2021)
  • Table 13. Reproductive Genetics In-Situ Hybridization (ISH) , by Region USD Million (2016-2021)
  • Table 14. Reproductive Genetics Comparative Genomic Hybridization (CGH) , by Region USD Million (2016-2021)
  • Table 15. Reproductive Genetics Microarray , by Region USD Million (2016-2021)
  • Table 16. Reproductive Genetics Polymerase Chain Reaction (PCR) , by Region USD Million (2016-2021)
  • Table 17. Reproductive Genetics: by Procedure(USD Million)
  • Table 18. Reproductive Genetics Pre-Natal Screening , by Region USD Million (2016-2021)
  • Table 19. Reproductive Genetics Pre-Implantation Genetic Testing , by Region USD Million (2016-2021)
  • Table 20. Reproductive Genetics Infertility Genetic Testing , by Region USD Million (2016-2021)
  • Table 21. Reproductive Genetics Carrier Screening , by Region USD Million (2016-2021)
  • Table 22. South America Reproductive Genetics, by Country USD Million (2016-2021)
  • Table 23. South America Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 24. South America Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 25. South America Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 26. South America Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 27. Brazil Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 28. Brazil Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 29. Brazil Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 30. Brazil Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 31. Argentina Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 32. Argentina Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 33. Argentina Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 34. Argentina Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 35. Rest of South America Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 36. Rest of South America Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 37. Rest of South America Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 38. Rest of South America Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 39. Asia Pacific Reproductive Genetics, by Country USD Million (2016-2021)
  • Table 40. Asia Pacific Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 41. Asia Pacific Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 42. Asia Pacific Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 43. Asia Pacific Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 44. China Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 45. China Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 46. China Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 47. China Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 48. Japan Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 49. Japan Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 50. Japan Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 51. Japan Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 52. India Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 53. India Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 54. India Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 55. India Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 56. South Korea Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 57. South Korea Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 58. South Korea Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 59. South Korea Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 60. Taiwan Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 61. Taiwan Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 62. Taiwan Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 63. Taiwan Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 64. Australia Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 65. Australia Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 66. Australia Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 67. Australia Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 72. Europe Reproductive Genetics, by Country USD Million (2016-2021)
  • Table 73. Europe Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 74. Europe Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 75. Europe Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 76. Europe Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 77. Germany Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 78. Germany Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 79. Germany Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 80. Germany Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 81. France Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 82. France Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 83. France Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 84. France Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 85. Italy Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 86. Italy Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 87. Italy Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 88. Italy Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 89. United Kingdom Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 90. United Kingdom Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 91. United Kingdom Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 92. United Kingdom Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 93. Netherlands Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 94. Netherlands Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 95. Netherlands Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 96. Netherlands Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 97. Rest of Europe Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 98. Rest of Europe Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 99. Rest of Europe Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 100. Rest of Europe Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 101. MEA Reproductive Genetics, by Country USD Million (2016-2021)
  • Table 102. MEA Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 103. MEA Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 104. MEA Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 105. MEA Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 106. Middle East Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 107. Middle East Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 108. Middle East Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 109. Middle East Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 110. Africa Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 111. Africa Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 112. Africa Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 113. Africa Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 114. North America Reproductive Genetics, by Country USD Million (2016-2021)
  • Table 115. North America Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 116. North America Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 117. North America Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 118. North America Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 119. United States Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 120. United States Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 121. United States Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 122. United States Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 123. Canada Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 124. Canada Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 125. Canada Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 126. Canada Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 127. Mexico Reproductive Genetics, by Type USD Million (2016-2021)
  • Table 128. Mexico Reproductive Genetics, by Application USD Million (2016-2021)
  • Table 129. Mexico Reproductive Genetics, by Technology USD Million (2016-2021)
  • Table 130. Mexico Reproductive Genetics, by Procedure USD Million (2016-2021)
  • Table 131. Reproductive Genetics: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Reproductive Genetics: by Type(USD Million)
  • Table 143. Reproductive Genetics Laboratory Developed Tests (LDT) , by Region USD Million (2022-2027)
  • Table 144. Reproductive Genetics Kits , by Region USD Million (2022-2027)
  • Table 145. Reproductive Genetics Reagents and Consumables , by Region USD Million (2022-2027)
  • Table 146. Reproductive Genetics: by Application(USD Million)
  • Table 147. Reproductive Genetics Aneuploidy , by Region USD Million (2022-2027)
  • Table 148. Reproductive Genetics Single Gene Disorders , by Region USD Million (2022-2027)
  • Table 149. Reproductive Genetics Structural Abnormalities , by Region USD Million (2022-2027)
  • Table 150. Reproductive Genetics Others , by Region USD Million (2022-2027)
  • Table 151. Reproductive Genetics: by Technology(USD Million)
  • Table 152. Reproductive Genetics PCR , by Region USD Million (2022-2027)
  • Table 153. Reproductive Genetics Sequencing , by Region USD Million (2022-2027)
  • Table 154. Reproductive Genetics In-Situ Hybridization (ISH) , by Region USD Million (2022-2027)
  • Table 155. Reproductive Genetics Comparative Genomic Hybridization (CGH) , by Region USD Million (2022-2027)
  • Table 156. Reproductive Genetics Microarray , by Region USD Million (2022-2027)
  • Table 157. Reproductive Genetics Polymerase Chain Reaction (PCR) , by Region USD Million (2022-2027)
  • Table 158. Reproductive Genetics: by Procedure(USD Million)
  • Table 159. Reproductive Genetics Pre-Natal Screening , by Region USD Million (2022-2027)
  • Table 160. Reproductive Genetics Pre-Implantation Genetic Testing , by Region USD Million (2022-2027)
  • Table 161. Reproductive Genetics Infertility Genetic Testing , by Region USD Million (2022-2027)
  • Table 162. Reproductive Genetics Carrier Screening , by Region USD Million (2022-2027)
  • Table 163. South America Reproductive Genetics, by Country USD Million (2022-2027)
  • Table 164. South America Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 165. South America Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 166. South America Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 167. South America Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 168. Brazil Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 169. Brazil Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 170. Brazil Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 171. Brazil Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 172. Argentina Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 173. Argentina Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 174. Argentina Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 175. Argentina Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 176. Rest of South America Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 177. Rest of South America Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 178. Rest of South America Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 179. Rest of South America Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 180. Asia Pacific Reproductive Genetics, by Country USD Million (2022-2027)
  • Table 181. Asia Pacific Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 182. Asia Pacific Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 183. Asia Pacific Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 184. Asia Pacific Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 185. China Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 186. China Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 187. China Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 188. China Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 189. Japan Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 190. Japan Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 191. Japan Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 192. Japan Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 193. India Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 194. India Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 195. India Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 196. India Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 197. South Korea Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 198. South Korea Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 199. South Korea Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 200. South Korea Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 201. Taiwan Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 202. Taiwan Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 203. Taiwan Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 204. Taiwan Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 205. Australia Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 206. Australia Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 207. Australia Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 208. Australia Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 209. Rest of Asia-Pacific Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 210. Rest of Asia-Pacific Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 211. Rest of Asia-Pacific Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 212. Rest of Asia-Pacific Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 213. Europe Reproductive Genetics, by Country USD Million (2022-2027)
  • Table 214. Europe Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 215. Europe Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 216. Europe Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 217. Europe Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 218. Germany Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 219. Germany Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 220. Germany Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 221. Germany Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 222. France Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 223. France Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 224. France Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 225. France Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 226. Italy Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 227. Italy Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 228. Italy Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 229. Italy Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 230. United Kingdom Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 231. United Kingdom Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 232. United Kingdom Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 233. United Kingdom Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 234. Netherlands Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 235. Netherlands Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 236. Netherlands Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 237. Netherlands Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 238. Rest of Europe Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 239. Rest of Europe Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 240. Rest of Europe Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 241. Rest of Europe Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 242. MEA Reproductive Genetics, by Country USD Million (2022-2027)
  • Table 243. MEA Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 244. MEA Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 245. MEA Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 246. MEA Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 247. Middle East Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 248. Middle East Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 249. Middle East Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 250. Middle East Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 251. Africa Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 252. Africa Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 253. Africa Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 254. Africa Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 255. North America Reproductive Genetics, by Country USD Million (2022-2027)
  • Table 256. North America Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 257. North America Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 258. North America Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 259. North America Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 260. United States Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 261. United States Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 262. United States Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 263. United States Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 264. Canada Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 265. Canada Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 266. Canada Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 267. Canada Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 268. Mexico Reproductive Genetics, by Type USD Million (2022-2027)
  • Table 269. Mexico Reproductive Genetics, by Application USD Million (2022-2027)
  • Table 270. Mexico Reproductive Genetics, by Technology USD Million (2022-2027)
  • Table 271. Mexico Reproductive Genetics, by Procedure USD Million (2022-2027)
  • Table 272. Reproductive Genetics: by Type(USD/Units)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Reproductive Genetics: by Type USD Million (2016-2021)
  • Figure 5. Global Reproductive Genetics: by Application USD Million (2016-2021)
  • Figure 6. Global Reproductive Genetics: by Technology USD Million (2016-2021)
  • Figure 7. Global Reproductive Genetics: by Procedure USD Million (2016-2021)
  • Figure 8. South America Reproductive Genetics Share (%), by Country
  • Figure 9. Asia Pacific Reproductive Genetics Share (%), by Country
  • Figure 10. Europe Reproductive Genetics Share (%), by Country
  • Figure 11. MEA Reproductive Genetics Share (%), by Country
  • Figure 12. North America Reproductive Genetics Share (%), by Country
  • Figure 13. Global Reproductive Genetics: by Type USD/Units (2016-2021)
  • Figure 14. Global Reproductive Genetics share by Players 2021 (%)
  • Figure 15. Global Reproductive Genetics share by Players (Top 3) 2021(%)
  • Figure 16. Global Reproductive Genetics share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Agilent Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 20. BGI (China) Revenue, Net Income and Gross profit
  • Figure 21. BGI (China) Revenue: by Geography 2021
  • Figure 22. CENTOGENE AG (Germany) Revenue, Net Income and Gross profit
  • Figure 23. CENTOGENE AG (Germany) Revenue: by Geography 2021
  • Figure 24. Fulgent Genetics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Fulgent Genetics, Inc. (United States) Revenue: by Geography 2021
  • Figure 26. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2021
  • Figure 28. Igenomix (Spain) Revenue, Net Income and Gross profit
  • Figure 29. Igenomix (Spain) Revenue: by Geography 2021
  • Figure 30. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Illumina, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Invitae Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Invitae Corporation (United States) Revenue: by Geography 2021
  • Figure 34. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 35. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2021
  • Figure 36. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. PerkinElmer, Inc. (United States) Revenue: by Geography 2021
  • Figure 38. Global Reproductive Genetics: by Type USD Million (2022-2027)
  • Figure 39. Global Reproductive Genetics: by Application USD Million (2022-2027)
  • Figure 40. Global Reproductive Genetics: by Technology USD Million (2022-2027)
  • Figure 41. Global Reproductive Genetics: by Procedure USD Million (2022-2027)
  • Figure 42. South America Reproductive Genetics Share (%), by Country
  • Figure 43. Asia Pacific Reproductive Genetics Share (%), by Country
  • Figure 44. Europe Reproductive Genetics Share (%), by Country
  • Figure 45. MEA Reproductive Genetics Share (%), by Country
  • Figure 46. North America Reproductive Genetics Share (%), by Country
  • Figure 47. Global Reproductive Genetics: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Agilent Technologies, Inc. (United States)
  • BGI (China)
  • CENTOGENE AG (Germany)
  • Fulgent Genetics, Inc. (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Igenomix (Spain)
  • Illumina, Inc. (United States)
  • Invitae Corporation (United States)
  • Laboratory Corporation of America Holdings (United States)
  • PerkinElmer, Inc. (United States)
Additional players considered in the study are as follows:
Myriad Genetics, Inc. (United States) , OPKO Health, Inc. (United States) , Quest Diagnostics (United States) , QIAGEN N.V. (Germany) , Thermo Fisher Scientific Inc. (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 225 Pages 86 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Reproductive Genetics Market Quantitative research analysis
Global Reproductive Genetics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Reproductive Genetics Market are by type [Laboratory Developed Tests (LDT), Kits and Reagents and Consumables], by end use application [Aneuploidy, Single Gene Disorders, Structural Abnormalities and Others].
The Reproductive Genetics Market is gaining popularity and expected to see strong valuation by 2027.
  • Increasing Awareness and Acceptance for Genetic Testing and Screening and Rising Maternal Age Leading to Pregnancy Complications Has Been Driving the Market Growth.

Know More About Global Reproductive Genetics Market Report?

Have a Query? Click Here

Other Related Reports

Smart Aquaculture Systems Comprehensive Study by Application (Fish, Crab, Shrimp, Others), System (Closed System, Open System), Aquaculture (Marine, Freshwater) Players and Region - Global Market Out...
$ 3500
Insect Biotechnology Comprehensive Study by Application (Biochemical Recycling, Pollination, Biological Control, Pest Management, Gene Therapy, Other), Technique (Recombinant DNA Technology, Transgen...
$ 3800
microRNA Based Diagnostic Kit Comprehensive Study by Mode of Delivery (Conjugation, Virus-Associated Delivery, Nanoparticles), End Use (Hospitals and Clinics, Diagnostic Laboratories, Academic & Gove...
$ 3800
Azadirachtin- Comprehensive Study by Application (Insecticides, Nematicides, Pesticides, Other), BY form (Liquid, Powder), BY End Use (Agriculture, Animal Husbandry, Horticulture, Cosmetics, Food & ...
$ 3800
Waste To Energy Technology Comprehensive Study by Type (Thermal, Thermo-Chemical, Mechanical-Thermal, Biochemical), Application (Heat, Fuels, Electricity), By Material (Cellulosic, Organic material),...
$ 3800
Hydrosols Comprehensive Study by Type (Organic, Conventional), Application (Perfumes, Skin Toners, Makeup, Aromatherapy, Alternative Medicines, Others), Distribution channel (Hypermarket & Supermark...
$ 3800